Related Experiment Video
Updated: Mar 3, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy
1University of Chicago Medicine, Section of Cardiology, United States.
Insights
Arrhythmogenic cardiomyopathy (AC) involves intercalated disc dysfunction. This review explores new genetic and epigenetic factors, like the Hippo pathway and microRNAs, contributing to AC development beyond desmosomal mutations.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Molecular Biology
Background:
- Arrhythmogenic cardiomyopathy (AC) is an intercalated disc disease affecting cardiac conduction.
- Previously known as ARVC/D, AC now includes left-dominant and biventricular forms.
- Desmosomal mutations explain only ~50% of AC cases, suggesting other mechanisms.
Purpose of the Study:
- To review newly identified genetic and epigenetic mechanisms in arrhythmogenic cardiomyopathy.
- To highlight the role of the Hippo pathway and microRNAs in AC pathogenesis.
- To broaden understanding of AC beyond desmosomal defects.
Main Methods:
- Literature review focusing on recent genetic and epigenetic findings in AC.
- Analysis of studies investigating desmosome-nucleus, gap junction, and ion channel crosstalk.
- Inclusion of animal and cellular studies on AC pathobiology.
Main Results:
- AC pathogenesis involves more than desmosomal mutations.
- Crosstalk between cellular components (desmosomes, nucleus, gap junctions, ion channels) is crucial.
- The Hippo pathway and microRNAs represent emerging mechanisms in AC.
Conclusions:
- AC is a complex disease with diverse genetic and epigenetic underpinnings.
- Understanding novel pathways like Hippo and microRNAs is vital for AC diagnosis and treatment.
- Further research into these mechanisms will advance AC management.
Abstract:
Arrhythmogenic cardiomyopathy (AC) is most commonly characterized as a disease of the intercalated disc that promotes abnormal cardiac conduction. Previously, arrhythmogenic cardiomyopathy was frequently referred to as arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D); however, genotype-phenotype studies have defined a broader phenotypic spectrum; with the identification of left-dominant and biventricular subtypes. Molecular insight into AC has primarily focused on mutations in desmosomal proteins and the downstream signaling pathways; however, desmosomal gene mutations can only be identified in approximately 50% of patients with AC. Animal and cellular studies have shown that in addition to abnormal biomechanical properties from changes in desmosome function, crosstalk from the desmosome to the nucleus, gap junctions, and ion channels are implicated in the pathobiology of AC. In this review, we highlight some of the newly identified genetic and epigenetic mechanisms that may lead to the development of AC including the role of the Hippo pathway and microRNAs. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure - edited by Jun Ren & Megan Yingmei Zhang.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

